We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Medical device development company DeGen Medical has introduced its 3D-printed porous titanium implant called Impulse AM for posterior interbody fusion. Impulse AM is claimed to be the first
Mevion Medical Systems today announced it has been selected by Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology to equip their new proton therapy
SummerBio LLC, a diagnostic company that provides affordable, high-quality, high-volume COVID-19 PCR testing, today announced that it is expanding its COVID-19 PCR testing capabilities and opening a new
Medtronic has secured approval from the US Food and Drug Administration (FDA) for its Freezor and Freezor Xtra cardiac cryoablation focal catheters for the treatment of paediatric atrioventricular
Radiology software company Sirona Medical has acquired Nines’ artificial intelligence (AI) capabilities for an undisclosed sum. The acquisition consists of clinical data pipeline, machine learning engines, AI powered
Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces enrollment has reached 95 subjects
REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up that is seeking to revolutionize precision oncology through diagnostic innovation, has launched its first genomic test. The HER2DX® test predicts the
MindMaze has raised $105m in a financing round to advance its digital therapeutic solutions for a range of neurological diseases. Led by Concord Health Partners, the financing round
Biopharmaceutical company Sorrento Therapeutics has purchased a majority stake in Zhengzhou Fortune Bioscience (FortuneBio) for an undisclosed sum. FortuneBio has expertise in the manufacturing of lateral flow diagnostic
Transit Scientific announced continued success with its XO Score Sheath Platform to treat highly-stenosed cardiovascular lesions using low pressure peripheral transluminal angioplasty (PTA). “Calcified stenotic lesions in the